Key result
Platelet-activating factor plays a central role in renal mesangial pathophysiology, and modulating mesangial cell responses to PAF may offer a targeted therapeutic approach to prevent glomerular injury.
Modulation of platelet-activating factor signaling in mesangial cells represents a potential therapeutic target for preventing glomerular injury and renal disease.
Hypothesis-generating for PAF-targeted glomerular therapies; leaves open clinical translation pending prospective trials.
Platelet-activating factor (PAF) is a powerful proinflammatory mediator that displays an exceedingly diverse spectrum of biological effects. Importantly, PAF is shown to participate in a broad range of pathologic conditions. This review focuses on the role that PAF plays specifically in the pathophysiology of the kidney, the organ that is both a source and a target of PAF. Renal mesangial cells are responsible for glomerular PAF generation and, ultimately, are the victims of its excessive production. Mesangial pathology is widely acknowledged to reflect glomerular damage, which culminates in glomerulosclerosis and proteinuria. Therefore, modulation of mesangial cell responses would offer a pathophysiology-based therapeutic approach to prevent glomerular injury. However, the currently available therapeutic modalities do not allow for targeted intervention into these processes. A more profound understanding of the mechanisms that govern PAF metabolism and signaling in mesangial cells is important, because it could facilitate the quest for improved therapies for renal patients on the basis of PAF as a drug target. Platelet-activating factor (PAF) is a powerful proinflammatory mediator that displays an exceedingly diverse spectrum of biological effects. Importantly, PAF is shown to participate in a broad range of pathologic conditions. This review focuses on the role that PAF plays specifically in the pathophysiology of the kidney, the organ that is both a source and a target of PAF. Renal mesangial cells are responsible for glomerular PAF generation and, ultimately, are the victims of its excessive production. Mesangial pathology is widely acknowledged to reflect glomerular damage, which culminates in glomerulosclerosis and proteinuria. Therefore, modulation of mesangial cell responses would offer a pathophysiology-based therapeutic approach to prevent glomerular injury. However, the currently available therapeutic modalities do not allow for targeted intervention into these processes. A more profound understanding of the mechanisms that govern PAF metabolism and signaling in mesangial cells is important, because it could facilitate the quest for improved therapies for renal patients on the basis of PAF as a drug target. A substantial body of literature is available on the role of platelet-activating factor (PAF) in renal pathophysiology. After the discovery of PAF by Jacques Benveniste,1Benveniste J. Henson P.M. Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.J Exp Med. 1972; 136: 1356-1377Crossref PubMed Scopus (969) Google Scholar a publication burst in the field of PAF in kidney research was observed. We summarize previous findings and point out conflicting reports and information gaps to revive the research interest with this review. Taking into account the recently acknowledged central role of mesangial cells in many forms of glomerular injury and the identification of a gene that, when overexpressed in mesangial cells, leads to an increase in PAF and mesangial matrix expansion, we set the boundaries of this review to focus on the role of PAF in mesangial pathophysiology. PAF (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a mediator of inflammation. By its chemical nature, PAF belongs to the ether phospholipids.2Vance D.E. Vance J.E. Biochemistry of Lipids, Lipoproteins, and Membranes.ed 4. Elsevier Science, New York2002Google Scholar Strictly speaking, PAF is not a single entity but rather a generic collective term for a heterogeneous class of molecular species with different saturated or mono-/di-unsaturated alkyl, acyl, or alkenyl chains attached through ether linkage at the sn-1 position of the glycerol backbone3McManus L.M. Woodard D.S. Deavers S.I. Pinckard R.N. PAF molecular heterogeneity: pathobiological implications.Lab Invest. 1993; 69: 639-650PubMed Google Scholar, 4Pinckard R.N. Woodard D.S. Showell H.J. Conklyn M.J. Novak M.J. McManus L.M. Structural and (patho)physiological diversity of PAF.Clin Rev Allergy. 1994; 12: 329-359Crossref PubMed Scopus (30) Google Scholar (Figure 1). The structural diversity translates into differences in biological potency, with the predominant and most biologically active species of PAF containing C16:0, C18:0, or C18:1 alkyl groups.4Pinckard R.N. Woodard D.S. Showell H.J. Conklyn M.J. Novak M.J. McManus L.M. Structural and (patho)physiological diversity of PAF.Clin Rev Allergy. 1994; 12: 329-359Crossref PubMed Scopus (30) Google Scholar, 5Schlondorff D. Goldwasser P. Neuwirth R. Satriano J.A. Clay K.L. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.Am J Physiol. 1986; 250: F1123-F1127PubMed Google Scholar PAF is a proinflammatory autacoid (a local hormone with paracrine effects) with pleiotropic effects. As a matter of fact, the term platelet-activating factor is a misnomer, because the effect of PAF on physiologic processes is not limited to and goes far beyond degranulation of platelets, the first effect that was documented.1Benveniste J. Henson P.M. Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.J Exp Med. 1972; 136: 1356-1377Crossref PubMed Scopus (969) Google Scholar, 6Barbaro J.F. Zvaifler N.J. Antigen induced histamine release from platelets of rabbits producing homologous PCA antibody.Proc Soc Exp Biol Med. 1966; 122: 1245-1247Crossref PubMed Scopus (48) Google Scholar, 7Henson P.M. Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.J Clin Invest. 1977; 60: 481-490Crossref PubMed Scopus (62) Google Scholar Diverse biological activities are ascribed to PAF, and it was found to be involved in the pathogenesis of a wide range of diseases.8Feuerstein G. Rabinovici R. Leor J. Winkler J.D. Vonhof S. Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.J Lipid Mediat Cell Signal. 1997; 15: 255-284Crossref PubMed Scopus (29) Google Scholar, 9Goldstein R.E. Feuerstein G.Z. Bradley L.M. Stambouly J.J. Laurindo F.R. Davenport N.J. Cardiovascular effects of platelet-activating factor.Lipids. 1991; 26: 1250-1256Crossref PubMed Scopus (17) Google Scholar, 10Schlondorff D. Neuwirth R. Platelet-activating factor and the kidney.Am J Physiol. 1986; 251: F1-F11PubMed Google Scholar In addition to the effects of the structural variation, the broad spectrum of PAF effects is achieved through a broad range of downstream mediators (Figure 2), via which PAF can elicit many of the reactions of inflammation and allergy, including enhanced leukocyte adhesion, chemotaxis, leukocyte degranulation, respiratory burst, and increased vascular permeability.11Braquet P. Hosford D. Braquet M. Bourgain R. Bussolino F. Role of cytokines and platelet-activating factor in microvascular immune injury.Int Arch Allergy Appl Immunol. 1989; 88: 88-100Crossref PubMed Scopus (87) Google Scholar, 12Jancar S. Braquet P. Sirois P. Interactions of arachidonic acid metabolites and platelet activating factor and of in J Biol Google Scholar, M. F. J. Platelet-activating factor in and from and the by and but not from Google Scholar A of cell as and renal mesangial cells, are shown to PAF, which can be via the and the D.E. Vance J.E. Biochemistry of Lipids, Lipoproteins, and Membranes.ed 4. Elsevier Science, New York2002Google Scholar, F. of platelet-activating factor and Exp PubMed Google Scholar, F. of platelet activating factor and ether and Clin Biol Google Scholar The a structural of in which the of a biologically which is and leads to the of of of mesangial PubMed Scopus Google Scholar, D. S. R. A single both platelet-activating factor and of and of Biol PubMed Scopus Google Scholar (Figure In the PAF from as in F. of the for the of platelet-activating factor (PAF) via in cells with PAF Biol PubMed Google Scholar, F. the in the of platelet-activating 1997; PubMed Scopus Google Scholar, D.S. F. The in the of platelet-activating of a in from the renal of Biol PubMed Google Scholar (Figure PAF is as a because it is to biologically by and M. platelet activating Lipid PubMed Scopus Google Scholar, platelet-activating factor PubMed Scopus Google Scholar, Platelet-activating factor in and PubMed Scopus Google Scholar This is by the that PAF at a as as a of in the of M. M. S. of platelet-activating factor of cells.Am J PubMed Scopus Google Scholar in However, it is the from is of its or to PAF mechanisms that and R.N. Woodard D.S. Showell H.J. Conklyn M.J. Novak M.J. McManus L.M. Structural and (patho)physiological diversity of PAF.Clin Rev Allergy. 1994; 12: 329-359Crossref PubMed Scopus (30) Google Scholar cell are to PAF, the kidney is an important, not source of PAF in the body because PAF is in the of patients and that S. D. P. M. of platelet-activating factor in from and in PubMed Scopus Google Scholar This is by the of PAF release by the J. J. of platelet-activating and from PubMed Scopus Google Scholar of the for PAF are in the of PAF as D. Goldwasser P. Neuwirth R. Satriano J.A. Clay K.L. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.Am J Physiol. 1986; 250: F1123-F1127PubMed Google Scholar, in and renal J PubMed Scopus Google Scholar of the and D.S. F. The in the of platelet-activating of a in from the renal of Biol PubMed Google Scholar of the is found in renal Production of PAF in the kidney can be to cells and renal of the is because increased PAF is in and S. R. R. J.J. J. of platelet-activating factor in and PubMed Scopus Google Scholar, S. M. J.J. J. A the glomerular of mediators and in Exp Immunol. PubMed Scopus (17) Google Scholar forms of renal glomerular leukocyte the renal cell glomerular mesangial and cells can PAF. PAF is in the and its are found to be in renal patients and with S. R. R. J.J. J. of platelet-activating factor in and PubMed Scopus Google Scholar, M. P. S. M. G. of platelet activating factor in patients with 1993; PubMed Scopus Google Scholar, M. D. J. F. G. Renal metabolism and of platelet-activating factor in the Biol PubMed Google Scholar, F. M. platelet-activating factor and in patients with 15: PubMed Scopus Google Scholar, G. S. P. Platelet-activating factor and PAF activities in patients with PubMed Scopus Google Scholar This it the of the renal of PAF. The kidney and S. R. R. J.J. J. of platelet-activating factor in and PubMed Scopus Google Scholar and the of PAF in the in the of increased glomerular M. D. J. F. G. Renal metabolism and of platelet-activating factor in the Biol PubMed Google Scholar its renal it a of PAF, because its in the at that in the renal a potential for a PAF its effects on target cells via a the PAF S. Platelet-activating factor PubMed Scopus Google Scholar In the kidney, is is a of its the in the renal with a in the by the the the the by the with the of platelet activating factor the PubMed Scopus Google Scholar In a and the of gene in this and M. S. Activation of platelet-activating factor renal inflammation and Invest. PubMed Scopus Google Scholar is the to species of the PAF class of PAF renal and glomerular in in and proteinuria. the effect of PAF is different the renal vascular be species In the PAF renal to a in glomerular and renal of PAF into the renal these effects of this effect is to be and not to Platelet-activating factor is a renal in the J Physiol. Google Scholar, of responses by platelet-activating factor in kidney.Am J Physiol. 1991; Google Scholar in the kidney However, in the PAF renal and effect on the of the and rabbit D. Neuwirth R. Platelet-activating factor and the kidney.Am J Physiol. 1986; 251: F1-F11PubMed Google Scholar, Platelet-activating factor is a renal in the J Physiol. Google Scholar In in the kidney, of PAF in an increase in R. S. M. G. Platelet-activating factor in Soc 1997; PubMed Google Scholar in the PAF in the kidney and M. M.J. F. J. of factor and platelet-activating factor in the pathogenesis of in Invest. 1994; Google Scholar a role of PAF in the of proteinuria. PAF is a mediator of and glomerular as shown in and PAF is in glomerular and of immune renal D. Neuwirth R. Platelet-activating factor and the kidney.Am J Physiol. 1986; 251: F1-F11PubMed Google Scholar, G. Role of platelet-activating factor in renal immune injury and J PubMed Scopus Google Scholar and in patients with and F. M. platelet-activating factor and in patients with 15: PubMed Scopus Google Scholar The PAF in renal processes of glomerular J. G. Platelet-activating factor in glomerular immune PubMed Scopus Google Scholar cell shown that PAF in the of kidney P. Braquet P. Role of platelet activating factor in kidney in the PubMed Scopus Google Scholar, role of platelet activating factor in renal PubMed Scopus Google Scholar J. M. M. J. in the of through a by the platelet-activating PubMed Scopus Google Scholar and G. M. Braquet P. of with a platelet-activating factor (PAF) PubMed Google Scholar, Role of platelet activating factor in and 1991; PubMed Scopus Google Scholar The that the mechanisms of PAF effects in the are and as and injury. PAF is enhanced in renal in S. G. F. G. renal in the The role of platelet-activating factor and of derived from and from Invest. Google Scholar of PAF with a effect on as by and renal and by the and P. Braquet P. Role of platelet activating factor in kidney in the PubMed Scopus Google Scholar The effect of PAF on because different the effect on PAF is in renal of different as A G. M. Braquet P. of with a platelet-activating factor (PAF) PubMed Google Scholar D. F. S. P. Braquet P. Platelet-activating factor renal in PubMed Scopus Google Scholar and role of platelet activating factor in renal PubMed Scopus Google Scholar, Role of platelet activating factor in and 1991; PubMed Scopus Google Scholar effects of PAF on are in in PAF effects to with PAF is to be involved in However, the PAF and is not but rather an increase in PAF in mesangial cells in the when PAF is as a of an S. M. J.J. J. A the glomerular of mediators and in Exp Immunol. PubMed Scopus (17) Google Scholar to matrix is a of renal of the PAF participate in renal of the kidney structural including the and the on renal cells, it a molecular of a of proinflammatory and that the PAF matrix in cultured mesangial M. R. D. J. Platelet-activating factor gene and of matrix in cultured and mesangial role of Soc 1997; PubMed Google Scholar cells, and M. J.J. J. of matrix in renal cells by PubMed Scopus Google Scholar the downstream molecular of PAF, arachidonic acid and factor matrix that in Mesangial cells are to be a source of glomerular PAF generation because in as PAF of with D. Goldwasser P. Neuwirth R. Satriano J.A. Clay K.L. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.Am J Physiol. 1986; 250: F1123-F1127PubMed Google Scholar of PAF by mesangial cells in could for glomerular because PAF a of effects on renal cells as However, physiologic and for PAF by mesangial cells in and Mesangial cells are with both and mechanisms of PAF and metabolism of in glomerular mesangial Biol PubMed Google Scholar, R. D. and metabolism of platelet-activating factor by cultured mesangial cells.Am J Physiol. 1989; Google Scholar The of the mechanisms mesangial cells in of glomerular PAF Renal mesangial cells the for PAF through both the and the it was shown that cultured mesangial cells to PAF, that PAF through the D. Goldwasser P. Neuwirth R. Satriano J.A. Clay K.L. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.Am J Physiol. 1986; 250: F1123-F1127PubMed Google Scholar, of of mesangial PubMed Scopus Google Scholar and of the in mesangial cells was S. of the of platelet activating of mesangial PubMed Scopus Google Scholar the are to different the to a the to PAF in to pathologic cultured mesangial cells are shown to PAF both in and on with factor G. G. Platelet-activating factor by cultured mesangial cells is by inhibitors.J Soc Google Scholar, F. R. S. G. is by mesangial cells and platelet-activating factor and cell J PubMed Scopus Google Scholar J. M. M.J. The effects of on platelet-activating factor in cultured glomerular mesangial PubMed Scopus Google Scholar D. J. J. and by PubMed Scopus Google Scholar and of inflammation. PAF by mesangial cells R. Satriano J.A. S. Clay D. of platelet activating factor in cultured mesangial 1989; PubMed Scopus Google Scholar which reflect of its rather that PAF is is by with the of PAF via the the of on mesangial cells with proinflammatory G. G. Platelet-activating factor by cultured mesangial cells is by inhibitors.J Soc Google Scholar the increase of not on a role for PAF is a that the of mechanisms to and the biological of this powerful proinflammatory is achieved physiologic in but it is shown that effect on mesangial PAF production. of the of PAF in mesangial cells by of its and G. G. Platelet-activating factor by cultured mesangial cells is by inhibitors.J Soc Google Scholar PAF by renal and of PAF through of and platelet-activating factor (PAF) in the Lipid Mediat Cell Signal. 1997; PubMed Scopus Google Scholar PAF and a effect on in mesangial of of PAF, which is by S. G. of on renal cell and effect on cell and platelet-activating factor J PubMed Scopus Google Scholar both and induced PAF PAF not in the but it is Mesangial cells PAF via an active that is by S. of platelet-activating factor is by in cultured mesangial Soc PubMed Google Scholar, G. platelet-activating J. PubMed Scopus Google Scholar and induced by release of PAF via this is the of PAF is achieved of its or the mechanisms that PAF its by a Mesangial cells PAF with the is on the of cultured mesangial R. D. and metabolism of platelet-activating factor by cultured mesangial cells.Am J Physiol. 1989; Google Scholar Mesangial a that mesangial and glomerular cells from the effects of PAF. to the of PAF in mesangial Mesangial cells on which a target for PAF and S. Platelet-activating factor PubMed Scopus Google Scholar, S. J.F. Platelet-activating factor (PAF) increase by both and in mesangial Clin Med. PubMed Scopus Google Scholar by mesangial cells is to PAF the of the effect of homologous is because different S. J.F. Platelet-activating factor (PAF) increase by both and in mesangial Clin Med. PubMed Scopus Google Scholar, S. homologous of PAF in mesangial cells.Am J Physiol. 1997; Google Scholar The the of of PAF can be by the of the that the of by PAF be or In of be PAF signaling in cultured mesangial M. J. M.J. Platelet-activating factor signaling in cultured mesangial Cell Physiol. PubMed Scopus Google Scholar to release and D. Satriano J.A. J. J. of platelet-activating factor and on arachidonic acid and of cultured mesangial Clin Invest. PubMed Scopus Google Scholar leukocyte S. G. of on renal cell and effect on cell and platelet-activating factor J PubMed Scopus Google Scholar mesangial cell F. R. S. G. is by mesangial cells and platelet-activating factor and cell J PubMed Scopus Google Scholar, D. Satriano J.A. J. J. of platelet-activating factor and on arachidonic acid and of cultured mesangial Clin Invest. PubMed Scopus Google Scholar, G. Bussolino F. factor of mesangial cells and PubMed Scopus Google Scholar, of glomerular mesangial cells in to platelet-activating factor and is by J. PubMed Scopus Google Scholar, D. F. Renal effects and mesangial cell induced by are by 1991; PubMed Scopus Google Scholar, G. S. D. of and on platelet-activating and in mesangial 1994; PubMed Scopus Google Scholar S. J.F. Platelet-activating factor (PAF) increase by both and in mesangial Clin Med. PubMed Scopus Google Scholar and matrix M. R. D. J. Platelet-activating factor gene and of matrix in cultured and mesangial role of Soc 1997; PubMed Google Scholar the of these molecular in in the of PAF as a and of and to mesangial The is to S. G. of on renal cell and effect on cell and platelet-activating factor J PubMed Scopus Google Scholar Therefore, PAF of the PAF the of and in mesangial S. J.F. Platelet-activating factor (PAF) increase by both and in mesangial Clin Med. PubMed Scopus Google Scholar This an increased of and in mesangial cells, to the of Mesangial is widely as an of glomerulosclerosis and a factor that in the and of renal M. J.J. class A and glomerular mesangial matrix in the PubMed Scopus Google Scholar, H.J. D. The role of in and 1994; PubMed Scopus Google Scholar, and in the of J PubMed Scopus Google Scholar, D. mechanisms of injury in the J 1993; PubMed Scopus Google Scholar Mesangial cells a and that D. R. of in glomerular mesangial cells.Am J Google Scholar This is of for mesangial cells in of glomerular by the of D. The mesangial cell cell is an Soc PubMed Scopus Google Scholar, J.D. mesangial and of PubMed Scopus Google Scholar, J.D. of by glomerular mesangial cells in and renal J 1997; PubMed Scopus Google Scholar PAF mesangial cell F. R. S. G. is by mesangial cells and platelet-activating factor and cell J PubMed Scopus Google Scholar, D. Satriano J.A. J. J. of platelet-activating factor and on arachidonic acid and of cultured mesangial Clin Invest. PubMed Scopus Google Scholar, G. Bussolino F. factor of mesangial cells and PubMed Scopus Google Scholar, of glomerular mesangial cells in to platelet-activating factor and is by J. PubMed Scopus Google Scholar, D. F. Renal effects and mesangial cell induced by are by 1991; PubMed Scopus Google Scholar, G. S. D. of and on platelet-activating and in mesangial 1994; PubMed Scopus Google Scholar through increase in of glomerular mesangial cells in to platelet-activating factor and is by J. PubMed Scopus Google Scholar, G. S. D. of and on platelet-activating and in mesangial 1994; PubMed Scopus Google Scholar, PAF and increase and in mesangial cells.Am J Physiol. Google Scholar, M. P. M.J. of by platelet-activating factor in cultured mesangial J. PubMed Scopus Google Scholar and F. R. S. G. is by mesangial cells and platelet-activating factor and cell J PubMed Scopus Google Scholar, G. Bussolino F. factor of mesangial cells and PubMed Scopus Google Scholar In because PAF mesangial cell cytokines PAF effects on mesangial cell PAF as a mediator of the effects on mesangial cell of F. R. S. G. is by mesangial cells and platelet-activating factor and cell J PubMed Scopus Google Scholar D. F. Renal effects and mesangial cell induced by are by 1991; PubMed Scopus Google Scholar and G. Bussolino F. factor of mesangial cells and PubMed Scopus Google Scholar A of mesangial in is to be a in because it a and glomerular and J.D. mesangial and of PubMed Scopus Google Scholar However, mesangial cell is the first that leads to matrix cell to which mesangial cells by as vascular and matrix that in mesangial and P. J. of glomerular mesangial cells in the pathogenesis of PubMed Scopus Google Scholar, S. P. J. and in mesangial modulation by and PubMed Scopus Google Scholar, S. of matrix by in glomerular mesangial Clin Invest. PubMed Scopus Google Scholar to the effect on and renal M. J.J. J. of matrix in renal cells by PubMed Scopus Google Scholar PAF matrix in cultured and mesangial M. R. D. J. Platelet-activating factor gene and of matrix in cultured and mesangial role of Soc 1997; PubMed Google Scholar the effect is on and the of the was by the increased production. the of the matrix PAF the of and of the Therefore, the molecular through which PAF participate in the mesangial matrix glomerular injury is to be by In with these in found mesangial matrix in to be with a gene for an that of which be for PAF M. P. R. of mesangial matrix in and identification of as a Soc PubMed Scopus (17) Google Scholar not the PAF and mesangial matrix but potential research that to and of the PAF is widely as a many of glomerular as mesangial expansion, and are on the PAF and mesangial cell PAF not in cultured mesangial M. R. D. J. Platelet-activating factor gene and of matrix in cultured and mesangial role of Soc 1997; PubMed Google Scholar, S. J.F. Platelet-activating factor (PAF) increase by both and in mesangial Clin Med. PubMed Scopus Google A role for platelet-activating factor in mesangial cell J 1993; PubMed Scopus Google Scholar the of PAF effect on of mesangial However, in renal PAF the effect of S. G. of on renal cell and effect on cell and platelet-activating factor J PubMed Scopus Google Scholar is are of PAF do not PAF on with or G. G. Platelet-activating factor by cultured mesangial cells is by inhibitors.J Soc Google PAF by R. S. R. G. mesangial cells to platelet-activating factor that in cultured PubMed Scopus (48) Google Scholar However, is a that are a target of PAF because PAF effects on of R. S. R. G. mesangial cells to platelet-activating factor that in cultured PubMed Scopus (48) Google Scholar and S. M. J.J. J. A the glomerular of mediators and in Exp Immunol. PubMed Scopus (17) Google Scholar to a in of the glomerular and, of its A mesangial cells and is as a responsible for the of D. The mesangial cell cell is an Soc PubMed Scopus Google Scholar PAF be of the cytokines by mesangial cells that with R. S. R. G. mesangial cells to platelet-activating factor that in cultured PubMed Scopus (48) Google Scholar The of the PAF and the of therapeutic are on the are that can or PAF from its are in the of and Platelet-activating factor a review of its role in and of PAF in the Allergy PubMed Scopus Google Scholar but in for G. G. G. Role of platelet-activating factor in PubMed Scopus Google Scholar G. P. Platelet-activating factor the cell and in J PubMed Scopus Google Scholar and kidney injury. with the in a of mesangial cell injury the in and structural in F. G. The platelet activating factor glomerular and in a of mesangial cell Soc 1991; PubMed Google Scholar The was recently in a of with at the first leads to a in of and of the and M. S. Activation of platelet-activating factor renal inflammation and Invest. PubMed Scopus Google Scholar target for that is an increase in PAF the that the of active PAF. with PAF and vascular PAF G. S. of a platelet-activating factor PubMed Scopus Google Scholar shown effects in for R.N. platelet-activating factor in with and 26: PubMed Scopus Google Scholar S. effects of platelet-activating factor and on in PubMed Scopus Google Scholar R. D. M. G. M. D. P. P. gene of platelet-activating and in PubMed Scopus Google Scholar and J. J. G. S. G. platelet-activating factor the of in the PubMed Scopus Google Scholar but effects on the kidney are findings that increased is with mesangial matrix expansion, through increased PAF M. P. R. of mesangial matrix in and identification of as a Soc PubMed Scopus (17) Google Scholar the for this in which is are PAF in the pathogenesis of renal because of its effects on of kidney (Figure However, a role of PAF in physiologic processes not be and A of on the of PAF in the of renal pathophysiology to be The information gaps and in this review which and potential of the PAF in mesangial are PAF and and are the effects of PAF on the of mesangial and PAF these is of because it would intervention to that biological of PAF not be to an proinflammatory but it be involved in a of processes. Renal of the available and is because it into the role that PAF plays in the the structural of PAF molecular most limited to and species are the in the drug is PAF The biological and of the range of molecular of the PAF, as the in and of PAF species in and and its potential to be in because the of the PAF molecular the and of renal
No takes yet. Share an insight, caveat, or question.
Reznichenko et al. (2015) conducted a review in Renal mesangial pathophysiology and glomerular injury. Platelet-activating factor (PAF) was evaluated. Platelet-activating factor plays a central role in renal mesangial pathophysiology, and modulating mesangial cell responses to PAF may offer a targeted therapeutic approach to prevent glomerular injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: